The Society for Cardiovascular Angiography & Interventions (SCAI) today released an expert consensus on the management of in-stent restenosis and stent thrombosis. The statement was published online ...

Angiographic outcomes are slightly worse with drug-coated balloons (DCB) than with second-generation DES for treating in-stent restenosis, an updated meta-analysis confirms. But experts say there are ...

Photo Credit: Adapted from Kirtane AJ. ISR: Why the why matters. mechanism of action identification and ISR on IVUS. Presented at: Fellows 2024. Las Vegas, NV. Two “leave-nothing-behind” ...

Please provide your email address to receive an email when new articles are posted on . NATIONAL HARBOR, Md. — Prompt recognition of in-stent thrombosis is critical to initiate treatment, according to ...

A new drug-eluting balloon can perform just as well as the standard treatment for patients with coronary in-stent restenosis (ISR) undergoing repeated percutaneous coronary intervention (PCI). These ...

Sirolimus, marketed under the trade name Rapamune, inhibits smooth muscle cell proliferation and neointimal formation following vascular injury. It also induces cell cycle arrest in the late G-1 phase ...

San Francisco — For the treatment of coronary artery in-stent restenosis, angioplasty with a drug-coated balloon (AGENT DCB; Boston Scientific) was superior to conventional balloon angioplasty in ...

Laser atherectomy uses light to break down hyperplastic tissue in an atherosclerotic plaque or restenosis of a stented lesion. In a new paper published in JACC Cardiovascular Interventions, ...

For interventionalists hoping that a new generation of coronary balloons might improve treatment of in-stent restenosis (ISR), contemporary registry data were encouraging. In a propensity ...

PHOENIX (May 18, 2023) – The Society for Cardiovascular Angiography & Interventions (SCAI) today release an expert consensus on the management of in-stent restenosis and stent thrombosis. The ...